Somalogic Inc (SLGC)
2.10 -0.10 (-4.55%) 01/06/24 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Jan 5th, 2024
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
Cash Flows From Operating Activities | |||||
Net Income | -109,157 | -87,547 | -53,015 | N/A | N/A |
Depreciation Amortization | 3,594 | 3,207 | 4,438 | N/A | N/A |
Accounts receivable | -9,366 | 383 | -13,306 | N/A | N/A |
Accounts payable and accrued liabilities | 2,340 | 6,460 | 4,025 | N/A | N/A |
Other Working Capital | 27,203 | 4,930 | -8,667 | N/A | N/A |
Other Operating Activity | -15,283 | 32,183 | 38,187 | 0 | 0 |
Operating Cash Flow | $-100,669 | $-40,384 | $-28,338 | $N/A | $N/A |
Cash Flows From Investing Activities | |||||
PPE Investments | -5,215 | -3,307 | -1,106 | N/A | N/A |
Net Acquisitions | -13,256 | N/A | N/A | N/A | N/A |
Purchase Of Investment | -186,687 | -279,918 | -45,702 | N/A | N/A |
Sale Of Investment | 287,700 | 101,206 | 37,273 | N/A | N/A |
Investing Cash Flow | $82,542 | $-182,019 | $-9,535 | $N/A | $N/A |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | 3,520 | N/A | N/A |
Debt Issued | N/A | 357,198 | N/A | N/A | N/A |
Debt Repayment | 0 | -36,512 | 0 | N/A | N/A |
Common Stock Issued | 5,185 | 3,947 | 1,105 | N/A | N/A |
Other Financing Activity | 0 | 172,858 | 184,141 | 0 | 0 |
Financing Cash Flow | $5,185 | $497,491 | $188,766 | $N/A | $N/A |
Exchange Rate Effect | -43 | -14 | -9 | N/A | N/A |
Beginning Cash Position | 440,268 | 165,194 | 14,310 | N/A | N/A |
End Cash Position | 427,283 | 440,268 | 165,194 | N/A | N/A |
Net Cash Flow | $-12,985 | $275,074 | $150,884 | $N/A | $N/A |
Free Cash Flow | |||||
Operating Cash Flow | -100,669 | -40,384 | -28,338 | N/A | N/A |
Capital Expenditure | -5,215 | -3,307 | -1,157 | N/A | N/A |
Free Cash Flow | -105,884 | -43,691 | -29,495 | 0 | 0 |